Pulmonology Medical News about Lung Disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Experience of Mycophenolate Mofetil in 10 Patients With Autoimmune-Related Interstitial Lung Disease Demonstrates Promising Effects
The American Journal of the Medical Sciences, 06/11/09

Saketkoo LA et al. - MMF is safe, well tolerated, and allows reduction or discontinuation of prednisone without worsening of symptoms or objective progression of disease. MMF is less toxic and its targeted antifibrotic properties make it a potentially more effective agent than CYC that may supplant it as a first-line agent or provide sensible post-CYC maintenance or synergistic strategy in the treatment of CTD-ILD.

<< Previous
Quantitative real-time PCR tests for diagnostic and prognostic...

Next >>
Effect of study duration on the interpretation of tuberculosis...

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09 Relevance Score: 69%

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09 Relevance Score: 68%

Radiochemotherapy in small-cell lung cancer
Expert Review of Anticancer Therapy, 10/20/09 Relevance Score: 68%

Nocturnal hypoxia and sleep disturbances in cystic fibrosis
Pediatric Pulmonology, 10/14/09 Relevance Score: 68%

Risk of Acute Exacerbation After Video-assisted Thoracoscopic Lung Biopsy for Interstitial Lung Disease
Journal of Bronchology, 10/14/09 Relevance Score: 68%